Oncolytic Viruses for Multiple Myeloma Therapy

Christine M. Calton(University of Arizona), Steffan T. Nawrocki(University of Arizona), Kevin R. Kelly(Keck Hospital of USC), Faiz Anwer(Cleveland Clinic), Jennifer S. Carew(University of Arizona)

Cancers

June 14, 2018

10.3390/cancers10060198

Cited by 27

Related Papers

Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics

|Clinical Cancer Research|2008|782

Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl–mediated drug resistance

|Blood|2007|485

Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapy

|Cancer Letters|2008|426

Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia

|Clinical Cancer Research|2015|355

Bortezomib Inhibits PKR-Like Endoplasmic Reticulum (ER) Kinase and Induces Apoptosis via ER Stress in Human Pancreatic Cancer Cells

|Cancer Research|2005|324